Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes.

Autor: Vetro, Calogero1 (AUTHOR) c.vetro@policlinico.unict.it, Di Giacomo, Valeria2 (AUTHOR) digiava@libero.it, Mannina, Donato2 (AUTHOR) donamanni@gmail.com, Magrin, Silvana3 (AUTHOR) silvana.magrin@libero.it, Mulè, Antonio3 (AUTHOR) a.mule@villasofia.it, Mitra, Maria Enza3 (AUTHOR) memitra@yahoo.com, Siragusa, Sergio4 (AUTHOR) sergio.siragusa@unipa.it, Duminuco, Andrea5 (AUTHOR) andrea.duminuco@gmail.com, Garibaldi, Bruno5 (AUTHOR) brunga93@gmail.com, Vadalà, Maria Cristina Emanuela1 (AUTHOR) m.cristinavadala@gmail.com, Di Raimondo, Francesco1 (AUTHOR) diraimon@unict.it, Palumbo, Giuseppe A.5,6 (AUTHOR) palumbo.ga@gmail.com
Zdroj: Journal of Clinical Medicine. Mar2022, Vol. 11 Issue 6, p1665-N.PAG. 13p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje